1Y Annualised Return
▼-6.44%
3Y Annualised Return
▲27.51%
5Y Annualised Return
▲28.87%
Over the past
Open
566.60
Prev. Close
570.40
Total Traded Value
84.13 L
Market Cap (in crs)
1,142.50
Face Value
10
Turnover (in lacs)
84.13
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
168.18 Cr | 146.55 Cr | 161.21 Cr | 147.28 Cr | 142.49 Cr |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
645.71 Cr | 614.97 Cr | 532.78 Cr | 482.12 Cr | 429.85 Cr | 397.53 Cr |
Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
11.58 Cr | 20.77 Cr | 26.33 Cr | 23.67 Cr | 18.6 Cr |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
82.35 Cr | 93.3 Cr | 72.9 Cr | 69.36 Cr | 62.25 Cr | 51.47 Cr |
Lincoln Pharmaceuticals Ltd reported a 3.9% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 28.5%.
Its expenses for the quarter were up by 0.4% QoQ and 28.1% YoY.
The net profit decreased 10.4% QoQ and increased 48.1% YoY.
The earnings per share (EPS) of Lincoln Pharmaceuticals Ltd stood at 9.3 during Q4FY25.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Period | Combined Delivery Volume | NSE+BSE Traded Volume |
---|---|---|
Day Rs | 32479 Rs | 50049 Rs |
Week Rs | 57358 Rs | 103884 Rs |
Month Rs | 50747 Rs | 97088 Rs |
Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
- | 1,494.57 | 101.01 | 185.5 | 141.84 | -7.72% | 17.04% | -15.90% | 35.87% | 90.55% | 0.35% | 21.67 | 41.89 | 1.41 | |
- | 1,492.00 | 130.48 | 328.04 | 224.45 | -5.81% | 5.23% | -18.50% | 64.71% | 104.58% | 1.11% | 37.59 | 41.89 | 6.23 | |
- | 1,229.66 | 115 | 317 | 133.60 | -8.75% | -11.44% | -50.59% | -38.32% | 78.38% | 0.00% | 51.69 | 41.89 | 4.31 | |
- | 1,060.47 | 148.5 | 245.7 | 211.62 | -3.17% | 16.01% | 0.00% | 0.00% | 0.00% | 0.71% | 22.39 | 41.89 | 3.25 | |
- | 1,115.96 | 481 | 1140 | 1,075.50 | 7.09% | 31.76% | 23.20% | 94.46% | 197.96% | 0.00% | 27.98 | 41.89 | 4.21 | |
Remus Pharmaceuticals Ltd. | - | 1,865.00 | - | - | - | - | - | - | - | - | - | - | - | - |
As of 18 Jun, 2025, Lincoln Pharmaceuticals share price is ₹572.4. The stock opened at ₹566.6 and had closed at ₹570.4 the previous day. During today’s trading session, Lincoln Pharmaceuticals share price moved between ₹566.60 and ₹576.80, with an average price for the day of ₹571.00. Over the last 52 weeks, the stock has recorded a low of ₹499.00 and a high of ₹979.50. In terms of performance, Lincoln Pharmaceuticals share price has declined by 38.1% over the past six months and has declined by 6.44% over the last year.
Lincoln Pharmaceuticals share price is ₹572.8 in NSE and ₹570.9 in BSE as on 18/6/2025.
Lincoln Pharmaceuticals share price in the past 1-year return was -6.1. The Lincoln Pharmaceuticals share hit a 1-year low of Rs. 499 and a 1-year high of Rs. 979.5.
The market cap of Lincoln Pharmaceuticals is Rs. 1142.5 Cr. as of 18/6/2025.
The PE ratios of Lincoln Pharmaceuticals is 13.88 as of 18/6/2025.
The PB ratios of Lincoln Pharmaceuticals is 1.7 as of 18/6/2025
You can easily buy Lincoln Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Please be aware that Lincoln Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.